Tokyo, Aug. 3 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062434) titled 'A phase II study of sotorasib plus panitumumab rechallenge in patients with KRAS G12C mutant metastatic colorectal cancer' on Aug. 3.
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Uncontrolled
Primary Sponsor:
Institute - Aichi Cancer Center
Condition:
Condition - Colorectal cancer
Classification by malignancy - Malignancy
Genomic information - YES
Objective:
Narrative objectives1 - To evaluate the clinical efficacy and safety of sotorasib plus panitumumab rechallenge in patients with KRAS G12C mutant metastatic color...